|Bid||63.81 x 28400|
|Ask||63.83 x 2100|
|Day's Range||63.69 - 64.55|
|52 Week Range||43.90 - 67.99|
|Beta (5Y Monthly)||1.19|
|PE Ratio (TTM)||424.93|
|Forward Dividend & Yield||2.00 (3.31%)|
|Ex-Dividend Date||May 02, 2022|
|1y Target Est||N/A|
Regeneron (REGN) announces positive data on a phase III study on cholesterol treatment Evkeeza.
(Bloomberg) -- Can Latin America seize the opportunities in front of it stemming from supply chain disruptions, cheap labor and a growing technology industry in order to revert a decade of tepid growth? Most Read from BloombergOne of the World’s Frothiest Housing Markets Turned Into a Seller’s Headache OvernightChina in Talks With Russia to Buy Oil for Strategic ReservesApple Shows AR/VR Headset to Board in Sign of Progress on Key Project Elon Musk Gets Defensive Over Twitter Meme as Harassment
Pfizer (PFE) is set to buy migraine drugmaker, Biohaven Pharmaceuticals for $11.6 billion. Bayer (BAYRY) beats Q1 earnings and sales expectations.